Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Opioid Induction in Emergency Laparotomy
NCT06772727Phase 4Completed
- Sponsor
- Cairo University
- Start
- Feb 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Lidocaine Hydrochloride Injection, without epinephrine in Postinduction hypotension (PIH) (2 arms), sponsored by Cairo University. Primary endpoint: Hypotension at 20 months. Started Feb 2025; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Postinduction hypotension (PIH)
Beyond the preview
Go deeper on NCT06772727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06772727.